Archive Projects

Project 120 – Protein complexes in bowel cancer

31 Oct 2013

Dr Raj Eri – $26,850 Inflammatory Bowel Diseases (IBD) affects over 70,000 mainly younger Australians and costs close to $3 billion per year to our economy. IBD patients suffer from chronic diarrhoea, intestinal bleeding and abdominal pain affecting the quality of life. About 3 in every 100 colitis patients might be expected to develop colorectal

Project 119: Macrolide resistance in patients with chronic respiratory infections

Dr Stephen Tristram – $17,325 Respiratory infections, including chronic obstructive pulmonary disease (COPD), represent a significant burden for Australian healthcare, accounting for approximately 18 million visits to general practitioners annually. COPD directly accounts for over 5000 deaths and is associated with another 7000 deaths, 55 000 hospitalisations and over $400 million healthcare costs in Australia

Project 116: New therapy for Cystic Fibrosis?

Dr Louise Roddam, School of Medicine, University of Tasmania – $74,500 Tasmania has the second highest incidence in the world of the devastating genetic disease cystic fibrosis that has no immediate prospects of a cure. Although this disease affects many parts of the human body, much of its debilitating effects are associated with the patient’s

Project 114 : How does the tuberculosis vaccine BCG protect against other infections?

17 Mar 2013

A grant was awarded Dr Katie Flanagan (Infectious Diseases specialist of the Launceston General Hospital) to assist a local researcher participate in a research project in conjunction with Monash University. $20,000. It is now well recognised that vaccines have a multitude of effects on the human immune system in addition to providing protection against the

Project 113: Honours Student Research Project – Follow-up of women who have had Gestational Diabetes Mellitus in Pregnancy

Emily Ingram (Honours student 2013) was awarded a scholarship to undertake a research project into Gestational Diabetes Mellitus $7,500 proudly supported by KPMG. Emily’s study showed: Gestational diabetes mellitus (GDM) is diabetes diagnosed in pregnancy and is associated with an increased life-long risk of developing type 2 diabetes (T2DM). Women with GDM are advised to